Epithra 50mg Injection
By Epithra
Rx
1 Injection in a Vial

Composition
Epirubicin(50mg)

Manufacturer - Glenmark Pharmaceuticals Ltd
Glenmark Pharmaceuticals Limited, B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai – 400 026.

Expires on or after
July, 2025

liver
When using Epithra 50mg Injection, caution should be exercised in patients with liver disease. It may be necessary to adjust the dosage of the injection in such cases. It is important to consult your doctor before starting treatment with Epithra 50mg Injection if you have any liver issues. Patients with severe liver disease are advised not to use Epithra 50mg Injection. Consulting with your doctor is recommended to ensure the safe use of the medication in liver-related conditions.

kidney
Epithra 50mg Injection is likely safe for patients with kidney disease. Data suggests dose adjustment may not be necessary. Consult your doctor. Consider lower doses if serum creatinine is > 5 mg/dL.

alcohol
"Avoid consuming alcohol while using Epithra 50mg Injection due to safety concerns."

driving
Epithra 50mg Injection can cause side effects like nausea and vomiting, which may affect your ability to drive temporarily.

pregnancy
Epithra 50mg Injection is not safe to use during pregnancy. It poses a risk to the developing baby. Only in life-threatening situations, the doctor might prescribe it if benefits outweigh risks. Consult your doctor before use.

breastfeeding
Epithra 50mg Injection is considered unsafe for use while breastfeeding due to the potential risk of causing toxicity to the baby.
Habit Forming | No |
Chemical Class | Anthracycline Derivative |
Therapeutic Class | - |
Action Class | Alkaloids-cytotoxic agents |
₹1060
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 11-Feb-2025